• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    'Ares, HPS Line Up $3 Billion Debt for Carlyle's Baxter Unit Bid' - Bloomberg

    7/23/24 1:15:47 PM ET
    $ARES
    $BAX
    $CG
    Investment Managers
    Finance
    Medical/Dental Instruments
    Health Care
    Get the next $ARES alert in real time by email

    https://www.bloomberg.com/news/articles/2024-07-23/ares-hps-line-up-3-billion-debt-for-carlyle-s-baxter-unit-bid?sref=y3YMCJ4e

    Get the next $ARES alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $ARES
    $BAX
    $CG

    CompanyDatePrice TargetRatingAnalyst
    The Carlyle Group Inc.
    $CG
    2/24/2026$67.00Outperform
    RBC Capital Mkts
    Ares Management Corporation
    $ARES
    2/9/2026$157.00Mkt Perform → Strong Buy
    Raymond James
    Ares Management Corporation
    $ARES
    2/6/2026Hold → Buy
    Deutsche Bank
    The Carlyle Group Inc.
    $CG
    12/11/2025$74.00Buy
    UBS
    Ares Management Corporation
    $ARES
    12/11/2025$201.00Neutral
    UBS
    Baxter International Inc.
    $BAX
    10/31/2025Buy → Hold
    Argus
    Ares Management Corporation
    $ARES
    10/14/2025$180.00Perform → Outperform
    Oppenheimer
    The Carlyle Group Inc.
    $CG
    10/3/2025$74.00Outperform
    BMO Capital Markets
    More analyst ratings

    $ARES
    $BAX
    $CG
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    October 18, 2024 - FDA Roundup: October 18, 2024

    For Immediate Release: October 18, 2024 Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency:  This week, FDA continues ongoing efforts to increase access and supply of IV and peritoneal dialysis (PD) fluids following Hurricane Helene-related damage to Baxter International Inc.’s facility in Marion, North Carolina. Specifically, FDA acted quickly to c

    10/18/24 4:16:25 PM ET
    $NVCR
    $BAX
    Medical/Dental Instruments
    Health Care

    $ARES
    $BAX
    $CG
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    RBC Capital Mkts initiated coverage on Carlyle Group with a new price target

    RBC Capital Mkts initiated coverage of Carlyle Group with a rating of Outperform and set a new price target of $67.00

    2/24/26 7:47:48 AM ET
    $CG
    Investment Managers
    Finance

    Ares Management upgraded by Raymond James with a new price target

    Raymond James upgraded Ares Management from Mkt Perform to Strong Buy and set a new price target of $157.00

    2/9/26 8:10:55 AM ET
    $ARES
    Investment Managers
    Finance

    Ares Management upgraded by Deutsche Bank

    Deutsche Bank upgraded Ares Management from Hold to Buy

    2/6/26 8:00:49 AM ET
    $ARES
    Investment Managers
    Finance

    $ARES
    $BAX
    $CG
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Olian Judy D. bought $59,726 worth of shares (480 units at $124.43), increasing direct ownership by 2% to 29,734 units (SEC Form 4)

    4 - Ares Management Corp (0001176948) (Issuer)

    2/24/26 6:50:31 PM ET
    $ARES
    Investment Managers
    Finance

    Director Bhutani Ashish bought $1,266,100 worth of shares (10,000 units at $126.61), increasing direct ownership by 42% to 34,071 units (SEC Form 4)

    4 - Ares Management Corp (0001176948) (Issuer)

    2/10/26 5:09:08 PM ET
    $ARES
    Investment Managers
    Finance

    Director Bhutani Ashish bought $1,413,300 worth of shares (10,000 units at $141.33), increasing direct ownership by 77% to 22,905 units (SEC Form 4)

    4 - Ares Management Corp (0001176948) (Issuer)

    3/13/25 8:14:14 PM ET
    $ARES
    Investment Managers
    Finance

    $ARES
    $BAX
    $CG
    SEC Filings

    View All

    SEC Form 10-K filed by The Carlyle Group Inc.

    10-K - Carlyle Group Inc. (0001527166) (Filer)

    2/27/26 4:13:57 PM ET
    $CG
    Investment Managers
    Finance

    The Carlyle Group Inc. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits

    8-K - Carlyle Group Inc. (0001527166) (Filer)

    2/26/26 7:00:39 AM ET
    $CG
    Investment Managers
    Finance

    SEC Form 10-K filed by Ares Management Corporation

    10-K - Ares Management Corp (0001176948) (Filer)

    2/25/26 9:08:59 AM ET
    $ARES
    Investment Managers
    Finance

    $ARES
    $BAX
    $CG
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Olian Judy D. bought $59,726 worth of shares (480 units at $124.43), increasing direct ownership by 2% to 29,734 units (SEC Form 4)

    4 - Ares Management Corp (0001176948) (Issuer)

    2/24/26 6:50:31 PM ET
    $ARES
    Investment Managers
    Finance

    Co-President Redett John C. was granted 9,114 shares, increasing direct ownership by 0.49% to 1,857,426 units (SEC Form 4)

    4 - Carlyle Group Inc. (0001527166) (Issuer)

    2/20/26 6:49:52 PM ET
    $CG
    Investment Managers
    Finance

    Chief Accounting Officer Andrews Charles Elliott Jr. was granted 343 shares, increasing direct ownership by 0.23% to 147,319 units (SEC Form 4)

    4 - Carlyle Group Inc. (0001527166) (Issuer)

    2/20/26 6:49:40 PM ET
    $CG
    Investment Managers
    Finance

    $ARES
    $BAX
    $CG
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Carlyle Presents Growth Outlook at 2026 Shareholder Update

    WASHINGTON and NEW YORK, Feb. 26, 2026 (GLOBE NEWSWIRE) -- Global investment firm Carlyle (NASDAQ:CG) is announcing its growth outlook and financial objectives at the 2026 Shareholder Update, beginning today at 8:30 a.m. EST. The program will include presentations by senior leadership, followed by a Q&A session. Carlyle will announce three-year financial targets to be achieved by the end of 2028, including: FRE of $1.9+ billionInflows of $200+ billionDE per common share of $6.00+ Carlyle is also announcing that its Board of Directors has approved a new $2 billion share repurchase authorization. The authorization provides the firm with flexibility to repurchase shares as part of its disc

    2/26/26 7:01:00 AM ET
    $CG
    Investment Managers
    Finance

    Sumitomo Heavy Industries and ARMADA's IMIA Formalize Strategic Alliance to Support U.S. Navy Readiness in Japan

    Signing at Sumitomo Heavy Industries headquarters marks the launch of a long-term partnership focused on operational readiness and mission-critical ship maintenance. Sumitomo Heavy Industries, Ltd. (SHI) and IMIA, an operating company of ARMADA, today announced the signing of their Alliance Agreement, launching a strategic partnership to support U.S. Navy operations in Japan and surrounding regions. The in-person signing ceremony was held at Sumitomo Heavy Industries' headquarters building, Sumitomo Kaikan, in Tokyo. The alliance brings together SHI's long-established industrial presence and execution capabilities that have supported the U.S. Navy 7th Fleet in Japan for decades with IMI

    2/25/26 1:10:00 PM ET
    $CG
    Investment Managers
    Finance

    Carlyle Secured Lending, Inc. Announces Financial Results For Fourth Quarter and Full Year Ended December 31, 2025, Declares First Quarter 2026 Dividend of $0.40 Per Common Share

    NEW YORK, Feb. 24, 2026 (GLOBE NEWSWIRE) -- Carlyle Secured Lending, Inc. (together with its consolidated subsidiaries, "we," "us," "our," "CGBD" or the "Company") (NASDAQ:CGBD) today announced its financial results for its fourth quarter and full year ended December 31, 2025. Alex Chi, CGBD's Chief Executive Officer, said, "As CGBD's newly appointed CEO, I look forward to continuing to build on Carlyle's strong track record and world-class platform. Building off record origination volume in the fourth quarter and full year 2025, we continue to expand our origination apparatus and are focused on further harnessing the full power of the OneCarlyle platform. The depth of our underwriting se

    2/24/26 4:05:00 PM ET
    $CG
    $CGBD
    Investment Managers
    Finance
    Finance: Consumer Services

    $ARES
    $BAX
    $CG
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13D/A filed by The Carlyle Group Inc.

    SC 13D/A - Carlyle Group Inc. (0001527166) (Subject)

    11/15/24 5:22:29 PM ET
    $CG
    Investment Managers
    Finance

    Amendment: SEC Form SC 13G/A filed by Ares Management Corporation

    SC 13G/A - Ares Management Corp (0001176948) (Subject)

    11/14/24 4:06:22 PM ET
    $ARES
    Investment Managers
    Finance

    Amendment: SEC Form SC 13G/A filed by Ares Management Corporation

    SC 13G/A - Ares Management Corp (0001176948) (Subject)

    11/14/24 4:05:07 PM ET
    $ARES
    Investment Managers
    Finance

    $ARES
    $BAX
    $CG
    Leadership Updates

    Live Leadership Updates

    View All

    Carlyle to Host 2026 Shareholder Update

    WASHINGTON and NEW YORK, Feb. 02, 2026 (GLOBE NEWSWIRE) -- Global investment firm Carlyle (NASDAQ:CG) announced today that it will host a Shareholder Update on Thursday, February 26, 2026. The Shareholder Update will include a series of presentations by the company's senior leadership team and will review Carlyle's growth outlook and financial objectives. Presentations will begin at 8:30 a.m. EST, followed by a Q&A session. Presentation materials and a live webcast will be posted on the day of the event and can be accessed on the Events & Presentations section of ir.carlyle.com. For those unable to join the live webcast, a replay will be available on the website following the event. Any

    2/2/26 8:01:00 AM ET
    $CG
    Investment Managers
    Finance

    Acentra Health Appoints Balajee Sethuraman as Executive Vice President and Chief Business Services Officer

    MCLEAN, Va., Jan. 27, 2026 (GLOBE NEWSWIRE) -- Acentra Health, a technology and health solutions company dedicated to accelerating better health outcomes for government and commercial clients and the populations they serve, today announced the appointment of Balajee Sethuraman as Executive Vice President and Chief Business Services Officer (CBSO), where he will lead the company's business services and delivery operations. This strategic addition to Acentra Health's executive leadership team supports its ongoing efforts to streamline and strengthen enterprise-wide delivery through a unified operating model. "Balajee is a transformative leader with exceptional experience scaling global team

    1/27/26 9:33:00 AM ET
    $CG
    Investment Managers
    Finance

    Acentra Health Appoints Deborah Ricci as Executive Vice President and Chief Financial Officer

    MCLEAN, Va., Jan. 14, 2026 (GLOBE NEWSWIRE) -- Acentra Health, a technology and health solutions company dedicated to accelerating better health outcomes for government and commercial clients and the populations they serve, today announced the appointment of Deborah Ricci as Executive Vice President and Chief Financial Officer (CFO). Ricci joins Acentra Health from Guidehouse Inc., where she most recently served as Partner and Chief Financial & Administrative Officer. In that role, she oversaw finance and accounting functions as well as quality, risk, security, and facilities, while supporting the firm's continued growth and operational transformation. Earlier in her career, Ricci held mu

    1/14/26 9:35:00 AM ET
    $CG
    Investment Managers
    Finance

    $ARES
    $BAX
    $CG
    Financials

    Live finance-specific insights

    View All

    Carlyle Presents Growth Outlook at 2026 Shareholder Update

    WASHINGTON and NEW YORK, Feb. 26, 2026 (GLOBE NEWSWIRE) -- Global investment firm Carlyle (NASDAQ:CG) is announcing its growth outlook and financial objectives at the 2026 Shareholder Update, beginning today at 8:30 a.m. EST. The program will include presentations by senior leadership, followed by a Q&A session. Carlyle will announce three-year financial targets to be achieved by the end of 2028, including: FRE of $1.9+ billionInflows of $200+ billionDE per common share of $6.00+ Carlyle is also announcing that its Board of Directors has approved a new $2 billion share repurchase authorization. The authorization provides the firm with flexibility to repurchase shares as part of its disc

    2/26/26 7:01:00 AM ET
    $CG
    Investment Managers
    Finance

    Carlyle Secured Lending, Inc. Announces Financial Results For Fourth Quarter and Full Year Ended December 31, 2025, Declares First Quarter 2026 Dividend of $0.40 Per Common Share

    NEW YORK, Feb. 24, 2026 (GLOBE NEWSWIRE) -- Carlyle Secured Lending, Inc. (together with its consolidated subsidiaries, "we," "us," "our," "CGBD" or the "Company") (NASDAQ:CGBD) today announced its financial results for its fourth quarter and full year ended December 31, 2025. Alex Chi, CGBD's Chief Executive Officer, said, "As CGBD's newly appointed CEO, I look forward to continuing to build on Carlyle's strong track record and world-class platform. Building off record origination volume in the fourth quarter and full year 2025, we continue to expand our origination apparatus and are focused on further harnessing the full power of the OneCarlyle platform. The depth of our underwriting se

    2/24/26 4:05:00 PM ET
    $CG
    $CGBD
    Investment Managers
    Finance
    Finance: Consumer Services

    Baxter Reports Fourth-Quarter 2025 Results

    Fourth-quarter sales from continuing operations of $2.97 billion increased 8% on a reported basis and 3% on an operational basis1,2 Fourth-quarter U.S. GAAP3 diluted earnings per share (EPS) (loss) from continuing operations of ($2.01); adjusted diluted EPS from continuing operations of $0.44 Company advances ongoing board of directors refreshment Baxter International Inc. (NYSE:BAX), a global medtech leader, today reported results for the fourth quarter of 2025. "While we delivered sales growth across all segments, our fourth-quarter results did not meet our expectations, underscoring the importance of our focus on driving continuous improvement across the enterprise," said And

    2/12/26 7:15:00 AM ET
    $BAX
    Medical/Dental Instruments
    Health Care